检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Long-term proteasome inhibition in newly diagnosed multiple myeloma (NDMM): US MM-6, a real-world study transitioning from bortezomib to ixazomib

Habte Yimer,Robert Rifkin,Stephen Noga,Sudhir Manda,Ruemu Birhiray,Christopher Yasenchak,Roger Lyons, Peter Kelly, Eric Chojnicki,Presley Whidden,Bingxia Wang,Brittany Demers, Larry Dollar,Ralph Boccia

Clinical Lymphoma Myeloma and Leukemia（2019）

引用 0|浏览16
暂无评分
关键词
clinical trials,Multiple myeloma,Proteasome Inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要